• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于三维重建的宫颈癌患者个体化肿瘤旁切除评估

Evaluation of individualized para-tumor resection of cervical cancer patients based on three-dimensional reconstruction.

作者信息

Wang Lu, Liu Ping, Duan Hui, Li Pengfei, Li Weili, Chen Chunlin

机构信息

Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

出版信息

Front Surg. 2023 Apr 27;10:1174490. doi: 10.3389/fsurg.2023.1174490. eCollection 2023.

DOI:10.3389/fsurg.2023.1174490
PMID:37181590
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10174429/
Abstract

OBJECTIVE

To discuss the possibility of individualizing the para-tumor resection range (PRR) in cervical cancer patients based on three-dimensional (3D) reconstruction.

METHODS

We retrospectively included 374 cervical cancer patients who underwent abdominal radical hysterectomy. Preoperative computerized tomography (CT) or magnetic resonance imaging (MRI) data sets were collected to get 3D models. Postoperative specimens were measured to evaluate surgical scope. Oncological outcomes of patients with different depths of stromal invasion and PRR were compared.

RESULTS

A PRR of 32.35 mm was found to be the cut-off point. For the 171 patients with stromal invasion <1/2 depth, patients with a PRR over 32.35 mm had a lower risk of death and higher 5-year overall survival (OS) than that in the ≤32.35 mm group (HR = 0.110, 95% CI: 0.012-0.988, = 0.046; OS: 98.8% vs. 86.8%, = 0.012). No significant differences were found in 5-year disease-free survival (DFS) between the two groups (92.2% vs. 84.4%, = 0.115). For the 178 cases with stromal invasion ≥1/2 depth, no significant differences were found in 5-year OS and DFS between groups (≤32.35 mm group vs. >32.35 mm group, OS: 71.0% vs. 83.0%, = 0.504; DFS: 65.7% vs. 80.4%, = 0.305).

CONCLUSION

In patients with stromal invasion <1/2 depth, the PRR should reach 32.35 mm to get more survival benefit and in patients with stromal invasion ≥1/2 depth, the PRR should reach 32.35 mm at least to avoid worse prognosis. Cervical cancer patients with different depths of stromal invasion may receive tailoring resection of the cardinal ligament.

摘要

目的

探讨基于三维(3D)重建对宫颈癌患者个体化确定肿瘤旁切除范围(PRR)的可能性。

方法

我们回顾性纳入了374例行腹式根治性子宫切除术的宫颈癌患者。收集术前计算机断层扫描(CT)或磁共振成像(MRI)数据集以获取3D模型。测量术后标本以评估手术范围。比较不同基质浸润深度和PRR患者的肿瘤学结局。

结果

发现PRR为32.35 mm是截断点。对于171例基质浸润<1/2深度的患者,PRR超过32.35 mm的患者死亡风险较低,5年总生存率(OS)高于PRR≤32.35 mm组(HR = 0.110,95% CI:0.012 - 0.988,P = 0.046;OS:98.8% 对86.8%,P = 0.012)。两组间5年无病生存率(DFS)无显著差异(92.2% 对84.4%,P = 0.115)。对于178例基质浸润≥1/2深度的病例,两组间5年OS和DFS无显著差异(PRR≤32.35 mm组对>32.35 mm组,OS:71.0% 对83.0%,P = 0.504;DFS:65.7% 对80.4%,P = 0.305)。

结论

对于基质浸润<1/2深度的患者,PRR应达到32.35 mm以获得更多生存益处;对于基质浸润≥1/2深度的患者,PRR至少应达到32.35 mm以避免预后更差。不同基质浸润深度的宫颈癌患者可接受主韧带的个体化切除。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23de/10174429/d4c4c28a09af/fsurg-10-1174490-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23de/10174429/f8467ccbb8d8/fsurg-10-1174490-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23de/10174429/6d514073f601/fsurg-10-1174490-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23de/10174429/7bc80300a0fd/fsurg-10-1174490-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23de/10174429/d4c4c28a09af/fsurg-10-1174490-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23de/10174429/f8467ccbb8d8/fsurg-10-1174490-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23de/10174429/6d514073f601/fsurg-10-1174490-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23de/10174429/7bc80300a0fd/fsurg-10-1174490-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23de/10174429/d4c4c28a09af/fsurg-10-1174490-g004.jpg

相似文献

1
Evaluation of individualized para-tumor resection of cervical cancer patients based on three-dimensional reconstruction.基于三维重建的宫颈癌患者个体化肿瘤旁切除评估
Front Surg. 2023 Apr 27;10:1174490. doi: 10.3389/fsurg.2023.1174490. eCollection 2023.
2
[Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study].[I a2-II a2期宫颈癌腹腔镜与开腹根治性子宫切除术后的长期肿瘤学结局:一项配对队列研究]
Zhonghua Fu Chan Ke Za Zhi. 2015 Dec;50(12):894-901.
3
[Effects of colpotomic approaches on prognosis and recurrence sites of stage Ⅰa2-Ⅱa2 cervical cancer after laparoscopic radical hysterectomy].[阴道切开术式对Ⅰa2-Ⅱa2期宫颈癌腹腔镜根治性子宫切除术后预后及复发部位的影响]
Zhonghua Fu Chan Ke Za Zhi. 2023 Jan 25;58(1):49-59. doi: 10.3760/cma.j.cn112141-20221022-00647.
4
[Long-term oncological outcomes of laparoscopic versus abdominal surgery in stage Ⅰa1 (LVSI)-Ⅰb1 cervical cancer patients with different tumor size: a big database in China].[不同肿瘤大小的Ⅰa1期(淋巴血管间隙浸润)-Ⅰb1期宫颈癌患者腹腔镜手术与开腹手术的长期肿瘤学结局:一项中国大型数据库研究]
Zhonghua Fu Chan Ke Za Zhi. 2020 Sep 25;55(9):589-599. doi: 10.3760/cma.j.cn112141-20200515-00411.
5
Comparison between robot-assisted radical hysterectomy and abdominal radical hysterectomy for cervical cancer: A multicentre retrospective study.机器人辅助根治性子宫切除术与腹式根治性子宫切除术治疗宫颈癌的比较:一项多中心回顾性研究。
Gynecol Oncol. 2020 May;157(2):429-436. doi: 10.1016/j.ygyno.2020.02.019. Epub 2020 Feb 15.
6
Comparison between laparoscopic and abdominal radical hysterectomy for low-risk cervical cancer: a multicentre retrospective study.腹腔镜与腹式根治性子宫切除术治疗低危宫颈癌的比较:一项多中心回顾性研究。
Arch Gynecol Obstet. 2022 Feb;305(2):449-458. doi: 10.1007/s00404-021-06185-6. Epub 2021 Aug 18.
7
Comparison of the Oncological Outcomes Between Robot-Assisted and Abdominal Radical Hysterectomy for Cervical Cancer Based on the New FIGO 2018 Staging System: A Multicentre Retrospective Study.基于国际妇产科联盟(FIGO)2018年新分期系统比较机器人辅助根治性子宫切除术与腹式根治性子宫切除术治疗宫颈癌的肿瘤学结局:一项多中心回顾性研究
Front Oncol. 2022 Jun 30;12:879569. doi: 10.3389/fonc.2022.879569. eCollection 2022.
8
Comparison of survival outcomes between radio-chemotherapy and radical hysterectomy with postoperative standard therapy in patients with stage IB1 to IIA2 cervical cancer: long-term oncological outcome analysis in 37 Chinese hospitals.比较 IB1 期到 IIA2 期宫颈癌患者接受放化疗与根治性子宫切除术联合术后标准治疗的生存结局:37 家中国医院的长期肿瘤学结局分析。
BMC Cancer. 2020 Mar 6;20(1):189. doi: 10.1186/s12885-020-6651-8.
9
Comparison of survival outcomes between laparoscopic surgery and abdominal surgery for radical hysterectomy as primary treatment in patients with stage IB2/IIA2 cervical cancer.腹腔镜手术与开腹手术治疗ⅠB2/ⅡA2 期宫颈癌根治术的生存结局比较。
J Obstet Gynaecol Res. 2021 Apr;47(4):1516-1526. doi: 10.1111/jog.14693. Epub 2021 Feb 1.
10
Hazard Ratio Analysis of Laparoscopic Radical Hysterectomy for IA1 With LVSI-IIA2 Cervical Cancer: Identifying the Possible Contraindications of Laparoscopic Surgery for Cervical Cancer.IA1伴淋巴血管间隙浸润(LVSI)-IIA2期宫颈癌腹腔镜根治性子宫切除术的风险比分析:确定腹腔镜手术治疗宫颈癌的可能禁忌证
Front Oncol. 2020 Jul 8;10:1002. doi: 10.3389/fonc.2020.01002. eCollection 2020.

本文引用的文献

1
Laparo-assisted vaginal radical hysterectomy as a safe option for Minimal Invasive Surgery in early stage cervical cancer: A systematic review and meta-analysis.腹腔镜辅助阴道根治性子宫切除术作为早期宫颈癌微创手术的一种安全选择:系统评价和荟萃分析。
Gynecol Oncol. 2022 Jul;166(1):188-195. doi: 10.1016/j.ygyno.2022.04.010. Epub 2022 May 2.
2
The role of endocervicoscopy in women with cervical intraepithelial neoplasia: a systematic review of the literature.宫颈上皮内瘤变患者行阴道镜检查的作用:文献系统评价。
Updates Surg. 2022 Aug;74(4):1239-1245. doi: 10.1007/s13304-021-01193-2. Epub 2021 Nov 5.
3
Cancer of the cervix uteri: 2021 update.
子宫颈癌:2021 年更新。
Int J Gynaecol Obstet. 2021 Oct;155 Suppl 1(Suppl 1):28-44. doi: 10.1002/ijgo.13865.
4
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition).肝细胞癌诊疗指南(2019年版)
Liver Cancer. 2020 Dec;9(6):682-720. doi: 10.1159/000509424. Epub 2020 Nov 11.
5
Urodynamic assessment of bladder storage function after radical hysterectomy for cervical cancer.宫颈癌根治性子宫切除术后膀胱储尿功能的尿动力学评估
Chin Med J (Engl). 2020 Oct 5;133(19):2274-2280. doi: 10.1097/CM9.0000000000001014.
6
NCCN Guidelines Insights: Cervical Cancer, Version 1.2020.NCCN 指南解读:宫颈癌,第 1.2020 版。
J Natl Compr Canc Netw. 2020 Jun;18(6):660-666. doi: 10.6004/jnccn.2020.0027.
7
Survival After Abdominal Q-M Type B versus C2 Radical Hysterectomy for Early-Stage Cervical Cancer.早期宫颈癌腹式Q-M型B与C2根治性子宫切除术的生存情况
Cancer Manag Res. 2019 Dec 31;11:10909-10919. doi: 10.2147/CMAR.S220212. eCollection 2019.
8
Sexual, bladder, bowel and ovarian function 1 year after robot-assisted radical hysterectomy for early-stage cervical cancer.早期宫颈癌行机器人辅助根治性子宫切除术后 1 年的性功能、膀胱功能、肠道功能和卵巢功能。
Acta Obstet Gynecol Scand. 2019 Nov;98(11):1404-1412. doi: 10.1111/aogs.13680. Epub 2019 Aug 12.
9
Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?中国当前癌症形势:2018 年全球癌症统计数据带来的是好消息还是坏消息?
Cancer Commun (Lond). 2019 Apr 29;39(1):22. doi: 10.1186/s40880-019-0368-6.
10
Reconstruction of three-dimensional vascular models for lymphadenectomy before surgery.术前淋巴结清扫三维血管模型的重建。
Minim Invasive Ther Allied Technol. 2020 Feb;29(1):42-48. doi: 10.1080/13645706.2019.1569533. Epub 2019 Feb 22.